NCT00640861View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 28, 2008

Primary Completion Date

April 21, 2015

Study Completion Date

April 21, 2015

Conditions
Breast Cancer
Interventions
BIOLOGICAL

CpG oligodeoxynucleotide

BIOLOGICAL

HER-2/neu peptide vaccine

BIOLOGICAL

MUC-1 peptide vaccine

BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

sargramostim

OTHER

immunoenzyme technique

OTHER

immunologic technique

Trial Locations (3)

55905

Mayo Clinic, Rochester

85259-5499

Mayo Clinic in Arizona, Scottsdale

Unknown

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00640861 - Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer | Biotech Hunter | Biotech Hunter